Michael Beaulieu | Integra LifeSciences Holdings Corporation |
Peter J. Arduini | Integra LifeSciences Holdings Corp. |
Glenn G. Coleman | Integra LifeSciences Holdings Corp. |
Travis Steed | Bank of America Merrill Lynch |
Shagun Singh | Wells Fargo Securities LLC |
David L. Turkaly | JMP Securities LLC |
Robbie J. Marcus | JPMorgan Securities LLC |
Craig William Bijou | Cantor Fitzgerald Securities |
Rajbir S. Denhoy | Jefferies LLC |
Jonathan Demchick | Morgan Stanley & Co. LLC |
Matthew Taylor | Barclays Capital, Inc. |
Steven Lichtman | Oppenheimer |
Jayson T. Bedford | Raymond James & Associates, Inc. |
William G. Inglis | Piper Jaffray & Co. |
Good day, and welcome to the Integra LifeSciences' Fourth Quarter and Full-Year 2017 Financial Results Conference Call.
As a reminder, today's call is being recorded. At this time, I'd like to turn the conference over to Mike Beaulieu, Director of Investor Relations. Please go ahead, sir.
Thank you, Andrea.